Application of CO2 laser evaporation in locally advanced melanomaVrielink, O. M., Kruijff, S., van Leeuwen, B. L. & Roodenburg, J. L. N., Mar-2019, In : Melanoma management. 6, 1, 10 p., 14.
Research output: Contribution to journal › Article › Academic › peer-review
Aim: This study aims to investigate the role of CO(2)laser evaporation in the treatment of melanoma patients with satellite or in-transit metastases. Materials & methods: Patients who underwent CO2 laser evaporation were retrospectively included between November 2002 and August 2018. The Sharplan 40C CO2 laser was used with a high pulse wave mode. Data concerning patient and tumor characteristics, CO2 laser evaporation and subsequent therapies were collected. Results:A total of 26patients were included. Median duration of local control was 5.5 months. The median number of lesions evaporated per treatment was three (1-16); patients received a median of three (1-19) treatments. Conclusion: In a selected group of melanoma patients with satellite or in-transit metastases, CO2 laser evaporation should be considered as treatment for local control.
|Number of pages||10|
|Publication status||Published - Mar-2019|
- CO2 laser, in-transit, melanoma, metastases, satellite, CARBON-DIOXIDE LASER, IN-TRANSIT MELANOMA, AMERICAN JOINT COMMITTEE, CUTANEOUS METASTASES, MALIGNANT-MELANOMA, IPILIMUMAB IMMUNOTHERAPY, TALIMOGENE LAHERPAREPVEC, TOPICAL IMMUNOTHERAPY, DISEASE PROGRESSION, ABLATION